Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Manish C. Choudhary, Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, Carlee Moser, Michael D. Hughes, Justin Ritz, Ruy M. Ribeiro, Ruian Ke, Joan Dragavon, Arzhang Cyrus Javan, Ajay Nirula, Paul Klekotka, Alexander L. Greninger, Courtney V. Fletcher, Eric S. Daar, David A. Wohl, Joseph J. Eron, Judith S. Currier, Urvi M. Parikh, Scott F. Sieg, Alan S. Perelson, Robert W. Coombs, Davey M. Smith, Jonathan Z. Li, for the ACTIV-2/A5401 Study Team, David R. Smith, Arzhang Cyrus Javan, Mark J Giganti, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott F. Sieg, William A. Fischer, Teresa H. Evering, Rachel Bender Ignacio, Sandra Wagner Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi